These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32373257)

  • 21. Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria-The National Stop Transmission of Polio Program.
    Michael CA; Waziri N; Gunnala R; Biya O; Kretsinger K; Wiesen E; Goodson JL; Esapa L; Gidado S; Uba B; Nguku P; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S373-S379. PubMed ID: 28838182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing the Supervision of Community Health Workers With WhatsApp Mobile Messaging: Qualitative Findings From 2 Low-Resource Settings in Kenya.
    Henry JV; Winters N; Lakati A; Oliver M; Geniets A; Mbae SM; Wanjiru H
    Glob Health Sci Pract; 2016 Jun; 4(2):311-25. PubMed ID: 27353623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact on child vaccination completion rates of short message services (SMS) reminders in developing countries.
    Davis R
    Pan Afr Med J; 2020; 35(Suppl 1):12. PubMed ID: 32373263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintaining high rates of measles immunization in Africa.
    Lessler J; Moss WJ; Lowther SA; Cummings DA
    Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
    Dhalaria P; Kumar P; Verma A; Priyadarshini P; Kumar Singh A; Tripathi B; Taneja G
    Vaccine; 2024 Jun; 42(17):3637-3646. PubMed ID: 38704248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
    Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
    Korave J; Bawa S; Ageda B; Ucho A; Bem-Bura DM; Onimisi A; Dieng B; Nsubuga P; Oteri J; Fiona B; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C76-C81. PubMed ID: 33461836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Potential Contribution of Supplementary Immunization Activities to Routine Immunization in Kebbi State, Nigeria.
    Omoleke SA; Getachew B; Igoh CS; Yusuf TA; Lukman SA; Loveday N
    J Prim Care Community Health; 2020; 11():2150132720932698. PubMed ID: 32508212
    [No Abstract]   [Full Text] [Related]  

  • 34. Beyond vertical and horizontal programs: a diagonal approach to building national immunization programs through measles elimination.
    Orenstein WA; Seib K
    Expert Rev Vaccines; 2016 Jul; 15(7):791-3. PubMed ID: 26967373
    [No Abstract]   [Full Text] [Related]  

  • 35. SMS-reminder for vaccination in Africa: research from published, unpublished and grey literature.
    Manakongtreecheep K
    Pan Afr Med J; 2017; 27(Suppl 3):23. PubMed ID: 29296158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    Wagai JN; Rhoda D; Prier M; Trimmer MK; Clary CB; Oteri J; Okposen B; Adeniran A; Danovaro-Holliday C; Cutts F
    PLoS One; 2021; 16(2):e0247415. PubMed ID: 33635913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data.
    Wariri O; Nkereuwem E; Erondu NA; Edem B; Nkereuwem OO; Idoko OT; Agogo E; Enegela JE; Sesay T; Conde IS; Kaucley L; Awuah AA; Abdullahi S; Luce RR; Banda R; Nomhwange T; Kampmann B
    Lancet Glob Health; 2021 Mar; 9(3):e280-e290. PubMed ID: 33607028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.
    Jean Baptiste AE; Masresha B; Wagai J; Luce R; Oteri J; Dieng B; Bawa S; Ikeonu OC; Chukwuji M; Braka F; Sanders EAM; Hahné S; Hak E
    Vaccine; 2021 Nov; 39 Suppl 3():C89-C95. PubMed ID: 33875267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.